Review and Interpretation of the 2024 ASCO Meeting

1. Recall and describe the newest developments in the treatment of breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, head/neck cancer, melanoma, hematological mallignancies.
2. Integrate multimodality treatment strategies, including radiation therapy, chemotherapy, immunotherapy, and targeted therapy, into the management of patients with cancer.
3. Based on the most up-to-date treatments described in the learning sessions, apply new knowledge and strategies about therapies of solid tumors and hematological malignancies into their clinical practice.

Pre-registration is now closed.   You can still register in person on-site on the day of the meeting July 13, 2024

Event will run from 8 a.m.-2:40 p.m.

Parking is available at the hotel and vouchers will be available at the registration desk when you arrive.  Please not that these vouchers are only good for the Marriott Downtown Indianapolis garage.

***Exhibitor registration has reached its maximum capacity and is now closed***

All educational and exhibit events will be held at the Indianapolis Marriott Downtown | 350 W. Maryland St., Indianapolis, IN 46225.  Click here to go directly to the Marriott site

Refund/Transferring/Cancellation Policy

All cancellations must be received (30) days prior to the activity date for a full refund. If cancellation is made at least (2) weeks prior to the activity date, a partial refund of 50% would be allowable. No refund is available for cancellations made after that point unless cause of cancellation is due to unforeseen extenuating circumstances. The date your request is received by our office will be considered the cancellation date. Requests received after the refund deadline will not be processed. 
If transferring registration, please reach out directly to the CEHP Office at [email protected] or call 317-274-0104.
IUSM reserves the right to cancel activities if extenuating circumstances make it necessary. You will be notified at the contact number indicated on your registration form. IUSM's liability is limited to the registration fee(s) paid.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

 Indianapolis Marriott Downtown | 350 W. Maryland St., Indianapolis, IN 46225

There is a room block available

Click here to go directly to the Marriott site

Mitigation of Relevant Financial Relationships

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Nabil Adra, MD
Associate Professor of Clinical Medicine
Indiana University School of Medicine

Course Director, Faculty, Owner

Advisor-Exelixis (Relationship has ended)|Advisor-Bristol-Myers Squib Aventis (Relationship has ended)|Advisor-Aveo (Relationship has ended)|Grant or research support-Exelixis |Grant or research support-Bristol-Myers Squib Aventis|Grant or research support-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc.|Advisor-Astellas|Grant or research support-Natera |Advisor-Sanofi-Aventis (Relationship has ended)

Rita Assi, MD, Physician
Assistant Professor
Indiana University

Faculty

Nothing to disclose

Tarah Ballinger, MD
Vera Bradley Foundation Scholar in Breast Cancer Research
Indiana University School of Medicine

Faculty

Advisor-Medscape|Consulting Fee-Novartis AG (Relationship has ended)

Gregory Durm, MD
Assistant Professor of Clinical Medicine
Indiana University School of Medicine

Faculty

Grant or research support-Merck and Company, Inc.|Grant or research support-Mirati|Grant or research support-AstraZeneca|Grant or research support-Bristol-Myers Squibb|Honoraria-Curio Science, Astra Zeneca, DAVA Oncology (Relationship has ended)

Matthew D Galsky, MD, FASCO
Mount Sinai School of Medicine

Faculty

Consulting Fee-BMS, Merck, Genentech, Astra Zeneca, Pfizer, |Consulting Fee-EMD Serono, SeaGen, Janssen, Curis|Consulting Fee-Asieris, Abbvie, Veracyte, Daichi, Aktis

Shadia Jalal, MD
Associate Professor of Medicine
Indiana Univeristy School of Medicine

Faculty

Nothing to disclose

Theodore Logan, MD
Associate Professor of Clinical Medicine
Indiana University School of Medicine

Faculty

Grant or research support-Abbott, Abraxis, Acceleron, Amgen, Astra Zeneca, Aveo, Agros, Biovex, BMS, Cerulean, Clinigen|Grant or research support-Merck, Millenium, NiKang, Novartis, Peloton, Pfizer, Prometheus, Roche, Synta, Threshold, Tracon|Grant or research support-Dynavax, EMD Serono, Eisaii, Glaxo Smith Kine, Iovance, Immatics, Eli Lilly|Grant or research support- Macrogenics, Med Immune|Consulting Fee-Prometheus

Kathy D Miller, MD, Physician
Professor of Medicine
IU School of Medicine Dept of Hem/Onc, IUSCCC

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Celcuity|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc.

Michael J Robertson, MD
Professor of Medicine
Indiana University School of Medicine

Faculty

Nothing to disclose

Bryan P Schneider, MD, Physician
Vera Bradley Professor of Oncology
Indiana University School of Medicine

Faculty

Nothing to disclose

Misty D Shields, MD, PhD, Physician
Assistant Professor
Indiana University

Faculty

Speakers Bureau-Jazz Pharmaceuticals (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Jazz Pharmaceuticals (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca (Relationship has ended)

Anita Turk, MD
Assistant Professor of Clinical Medicine
Indiana University School of Medicine

Faculty

Grant or research support-Eli Lilly and Company|Consulting Fee-KLM Solutions|Grant or research support-Merck and Company, Inc.|Grant or research support-Takeda Pharmaceuticals, Inc. (Relationship has ended)

Jennifer M King, MD, Physician
Assistant Professor of Clinical Medicine
Indiana University School of Medicine

Faculty, Other Planning Committee Member

Nothing to disclose

Lianne Valler, RN, Nurse
RN
IU School of Medicine

Nurse Planner

Nothing to disclose

Christopher A Fausel, PharmD, Pharmacist
Oncology Pharmacist, Precision Genomics
IU Health

Pharmacy Planner

Nothing to disclose

Saturday, July 13, 2024

Exhibitor registration has reached its maximum capacity and is now closed.  (Rates per table were $1500 w/two representatives.)

Amenities Include:
a. Use of a single table and two chairs in the exhibit space.
b. Exhibitor identification signage, such as a table top sign, table runner, or banner, provided by the exhibitor, is permitted on the table.
c. Permission for two representatives to exhibit the product/service..  Break service and lunch provided
d. A single set of program materials per Exhibitor (not per representative), if program materials have been created and distributed to attendees. However, in no event will IUSM CEHP provide a list of program attendees in program materials given to Exhibitors.
e. If you wish to attend presentations: remove your name tag before entering meeting space and refrain from wearing or taking items with company name/logo into meeting space. Also refrain from asking questions or leading the discussion in any ways.
f. IU School of Medicine prohibits exhibitors from providing gifts, regardless of market value. Please do not distribute any gift items with company or product names/logos. Product brochures allowed on exhibit tables.
g. Acknowledgment at the activity. Pursuant to ACCME SCS 6.4, such acknowledgement will not contain the logo of any individual Exhibitor.  Rather, the course director (or other CME representative) will acknowledge the exhibitors and the availability of the exhibit space generally for attendees who choose to visit it.

Email CEHP at [email protected] for copy of a W9. 
For questions or technical issues, please contact [email protected] or 317-274-0104.

IMPORTANT:  Specific information regarding logistics and setup will be distributed to exhibit registrants several days prior to the activity date with detailed contact information.